GaldermaReceivesU.S.FDAApprovalforRestylaneLyftfortheEnhancementoftheChinProfile
===2025/11/5 21:22:08===
product in my clinic, supported by my own experience and over two decades of global safety data, so I’m pleased to now be able to also offer patients its benefits in the chin.”
ALIA S. BROWN, M.D. FAAD
ATLANTA BIOMEDICAL CLINICAL RESEARCH AND GEORGIA DERMATOLOGY PARTNERS
COSMETIC DERMATOLOGIST
Regulatory applications for Restylane Lyft for use on the chin will continue to be submitted and assessed by additional authorities globally. Galderma is working to bring this expanded indication to as many countries as possible.
IMPORTANT SAFETY INFORMATION
Restylane Lyft with Lidocaineis indicated for deep implantation into the facial tissue for the correction of moderate-to-severe facial wrinkles and folds, such as nasolabial folds, for cheek augmentation and for th
=*=*=*=*=*=
当前为第5/13页
下一页-上一页-
=*=*=*=*=*=
返回新闻列表
返回网站首页